期刊文献+

抗肿瘤血管靶向药物的研究进展 被引量:5

Progress in anti-angiogenesis targeted drugs
下载PDF
导出
摘要 肿瘤血管生成对大多数实体瘤的生长和转移具有重要意义,是多步骤多因素参与的复杂病理过程。选择肿瘤血管生成中的一些关键环节或参与的重要因子作为靶点,研制应用特异性肿瘤血管生成抑制剂或抗体,以靶向调控肿瘤血管生成,控制肿瘤的生长和转移,达到治疗肿瘤的目的。本文对近年来肿瘤血管生成机制和肿瘤血管生成抑制剂的研究进展进行综述。 Tumor angiogenesis is a complicated pathologic process, which plays an important role in the growth and metastasis of most solid tumors. Targeting at the angiogenesis and inhibiting tumor growth or metastasis, specific antibodies or inhibitors of tumor angiogenesis have been developed for this purpose. We summarized recent researches about the mechanism of tumor angiogenesis and the development of tumor angiogenesis inhibitors in this review.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2009年第6期401-405,共5页 China Oncology
关键词 肿瘤 抗血管形成 血管内皮生长因子 靶向药物 生物治疗 neoplasm anti-angiogenesis vascular endothelial growth factor targeted drug biological therapy
  • 相关文献

参考文献3

二级参考文献26

  • 1王学文,杨天楹.难治性和复发性骨髓瘤的治疗进展[J].国外医学(输血及血液学分册),1993,16(1):35-37. 被引量:11
  • 2郭翔,曹素梅,洪明晃,张昌卿,韩安家,向燕群,侯景辉,闵华庆.VEGF蛋白检测对预测鼻咽癌远处转移风险的价值[J].癌症,2004,23(10):1171-1175. 被引量:22
  • 3Wakisaka N, Wen Q H, Yoshizaki T, et al. Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma [J].Laryngoscope, 1999, 109(5 ) : 810-814.
  • 4Qian C N, Zhang C Q, Guo X, et al. Elevation of serum vascular endothelial growth faetor in male patients with metastatic nasopharyngeal carcinoma [J]. Cancer, 2000,88(2) :255-261.
  • 5Wu H G, Sunagawa M, En L J, et al. The relationship between microvessel density, the expression of vascular endothel ialgrowth factor (VEGF), and the extension of nasopharyngeal carcinoma [ J ]. Laryngoscope, 2000,110(12) :2066-2069.
  • 6Hui E P, Chan A, Pezzella F, et al. Coexpression of hypoxiainducible factors lct and 2ct, carbonit, anhydrase Ⅸ, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival [J]. Clin Can Res, 2002,8(8):2595-2604.
  • 7Kato N, Yoshikawa M, Miyazaki T, et al. Expression of vascular endothelial growth factor (VEGF) and its receptors(Fh-1 & Flk-1 ) in esophageal squamous cell carcinoma[J].Anticancer Res, 2002,22 (6C) : 3977-3984.
  • 8Ghanem M A, Steenbrugge G J, Sudaryo M K, et al. Expression and prognostic relevance of vascular endothelial growth factor(VEGF) and its receptor (FLT-1) in nephroblastoma [J]. J Clin Pathol, 2003,56(2) : 107-113.
  • 9Kranz A, Mattfeldt T, Waltenberger J. Molecular mediators of tumor angiogenesis: enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer[J]. lnt J Cancer, 1999,84(3):293-298.
  • 10Volm M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Fh-1 in squamous cell lung cancer [J]. lnt J Cancer, 1997,74( 1 ) :64-68.

共引文献23

同被引文献49

  • 1王振宇,陈晓鹏.肿瘤血管生成的靶向调控及其药物研究进展[J].中国现代药物应用,2007,1(9):67-69. 被引量:4
  • 2杨桂旺,庄国洪,王阶平,李文珠,吴娜,颜江华.用于肿瘤血管靶向治疗的RGD/tTF融合蛋白的表达及活性鉴定[J].中国免疫学杂志,2006,22(4):327-330. 被引量:5
  • 3陈陵,陈婷,蔡永国,汤旭东,李晶晶,房殿春,罗元辉,余松涛,杨仕明.胃黏膜癌变过程中hTERT和相关基因表达的变化及其临床意义[J].胃肠病学和肝病学杂志,2006,15(5):443-447. 被引量:13
  • 4钟琳,任美萍,岳永花,肖顺汉.以抑制肿瘤新生血管为靶点的抗肿瘤药物研究进展[J].四川生理科学杂志,2007,29(1):28-31. 被引量:1
  • 5Huang X,Molema G,King S,et al.Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature.Science,1997,275:54 7-550.
  • 6Ran S,Gao B,Duffy S,et al.Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature.Cancer Res,1998,58:4646-4653.
  • 7Nilsson F,Kosmehl H.Zardi L,et al.Targeted delivery of tissue factor to the ED-B domain of fibronectin,a marker of angiogenesis,mediates the infarction of solid tumors in mice.Cancer Res,2001,61:711-716.
  • 8Hu P,Yan J,Sharifi J,et al.Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosis.Cancer Res,2003,63:5046-5053.
  • 9Liu C,Huang H,Donate F,et al.Prostate-specific membrane antigen directed selective thrombotic infarction of tumors.Cancer Res,2002,62:5470-5475.
  • 10Liu C,Dickinson C,Shobe J,et al.A hybrid fibronectin.motif protein as an integrin targeting selective tumor vascular thrombogen.Mol Cancer Ther,2004,3:793-801.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部